Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

T-cell leukemia

Retroviruses Human T-cell leukemia virus (HTLV) Human T-lymphocytic tumors... [Pg.477]

Lymphomas not included in Working Formulation mycosis fungoides, mantle cell lymphoma, monocytoid B-cell lymphoma, mucosa-associated lymphoid tissue (MALT), anaplastic large cell lymphoma, angiocentric lymphoma, angioimmunoblastic lymphadenopathy (AILD), Castleman s disease, adult T-cell leukemia/lymphoma. [Pg.1376]

Niwa R, Shoji-Hosaka E, Sakurada M, et al. Defucosylated chimeric anti-CC chemokine receptor 4 IgGl with enhanced antibody-dependent cellular cytotoxicity shows potent therapeutic activity to T-cell leukemia and lymphoma. Cancer Res 2004 64 2127-2133. [Pg.350]

Ishida T, Iida S, Akatsuka Y, et al. The CC chemokine receptor 4 as a novel specific molecular target for immunotherapy in adult T-cell leukemia/lymphoma. Clin Cancer Res 2004 10 7529-7539. [Pg.350]

Adult T-cell leukemia Human T-cell Retrovirus RNA... [Pg.166]

Kalyanaraman, D. Mann, G. D. Sidhu, R. E. Stahl, S. Zolla-Prazner, J. Leibowitch, and M. Popovic, Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS), Science 220 865 (1983). [Pg.331]

Pentostatin (2,-deoxycoformycin) is an adenosine analog that is a potent inhibitor of adenosine deaminase. Pentostatin is particularly useful for treating T-cell leukemia since malignant T cells have higher levels of adenosine deaminase than most cells. Similar to individuals that are genetically deficient in adenosine deaminase, treat-... [Pg.544]

Peno statin Adenosine analog T-cell leukemia Inhibits adenosine deaminase suppresses T and B cells... [Pg.547]

HTLV I Endemic in W Indies and SW Japan transmission via blood, human milk can cause adult T-cell leukemia, and HTLV I-associated myelopathy and tropical spastic paraparesis... [Pg.196]

HTLV II Uncommon, sporadic occurence transmission via blood can cause hairy T-cell leukemia... [Pg.196]

While dEpoB performed similarly to paclitaxel in sensitive tumor xenografts (MX-1 human mammary and HT-29 colon tumor), clearly superior effects of dEpoB were observed against MDR tumors under these slow infusion conditions. Thus, dEpoB (6 h, Q2D, 30 mg/kg x 5 doses, i.v.) demonstrated a foil curative effect when administered to nude mice bearing the resistant human lymphoblastic T-cell leukemia,... [Pg.31]

Kobe B, Center RJ, Kemp BE, Poumbouris P. 1999. Crystal structure of human T cell leukemia virus type 1 gp21 ectodomain crystallized as a maltose binding protein chimera reveals structural evolution of retroviral transmembrane proteins. Proc Natl Acad Sci USA 96 4319-4324. [Pg.478]

MM = multiple myeloma ATL = adult T-cell leukemia ALL = acute lymphoblastic leukemia CLL = chronic lymphocytic leukemia FCC = follicular center cell lymphoma DLC = diffuse large cell lymphoma TRB = T-cell rich B-cell lymphoma ALCL = anaplastic large cell lymphoma MALT = mucosa-associated lymphoid tissue-type lymphoma LC = lung cancer CMM = cutaneous malignant melanoma TCC = transitional cell carcinoma CSCC = cutaneous squamous cell carcinoma. [Pg.125]

K3. Kinoshita, K., Kamihira, S., Yamada, Y, Amagasaki, T., Ikeda, S., Momita, S., and Ichimaru, M., Adult T-cell leukemia-lymphoma in the Nagasaki district. In Adult T-Cell Leukemia and Related Disease (M. Hanaoka, K. Takatsuki, and M. Shimoyama, eds.), pp. 167-184. Japan Scientific Societies Press, Tokyo, 1982. [Pg.135]

K5. Knipping, E., Debatin, K. M., Strieker, K., Heilig, B., Eder, A., and Krammer, P. H., Identification of soluble APO-1 in supernatants of human B- and T-cell lines and increased serum levels in B- and T-cell leukemias. Blood 85, 1562-1569 (1995). [Pg.135]

Shimoyama, M., Diagnostic criteria and classification of clinical subtypes of adult T-cell leukemia-lymphoma. A report from the Lymphoma Study Group (1984-87). Br. J. Haematol. 79,428-437 (1991). [Pg.136]

T2. Tamiya, S., Ftoh, K., Suzushima, H., Takatsuki, K., and Matsuoka, M., Mutation of CD95 (Fas/Apo-1) gene in adult T-cell leukemia cells. Blood 91, 3935-3942 (1998). [Pg.136]

Kasai T, Iwanaga Y, Iha H et al. Prevalent loss of mitotic spindle checkpoint in adult T-cell leukemia confers resistance to microtubule inhibitors. JBiol Chem 2002 277 5187-5193. [Pg.247]


See other pages where T-cell leukemia is mentioned: [Pg.4]    [Pg.1373]    [Pg.343]    [Pg.343]    [Pg.200]    [Pg.54]    [Pg.187]    [Pg.706]    [Pg.529]    [Pg.444]    [Pg.444]    [Pg.450]    [Pg.450]    [Pg.222]    [Pg.254]    [Pg.12]    [Pg.310]    [Pg.111]    [Pg.136]    [Pg.136]    [Pg.351]    [Pg.233]    [Pg.557]    [Pg.206]    [Pg.550]    [Pg.292]    [Pg.44]    [Pg.241]   
See also in sourсe #XX -- [ Pg.254 ]

See also in sourсe #XX -- [ Pg.461 , Pg.462 ]




SEARCH



Adult T-cell leukemia

Human T-cell leukemia virus

Human T-cell leukemia virus type I (HTLV

Leukemia cells

T-cell acute lymphoblastic leukemia

T-cell leukemia-lymphoma

© 2024 chempedia.info